HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Wolfgang Enghardt Selected Research

trypsin carboxypeptidase peptide inhibitor

12/2017Modeling tumor control probability for spatially inhomogeneous risk of failure based on clinical outcome data.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Wolfgang Enghardt Research Topics

Disease

14Neoplasms (Cancer)
12/2020 - 05/2002
2Brain Neoplasms (Brain Tumor)
04/2020 - 11/2017
1Prostatic Neoplasms (Prostate Cancer)
04/2020
1Photosensitivity Disorders (Photodermatitis)
08/2019
1Phototoxic Dermatitis (Phototoxicity)
08/2019
1Head and Neck Neoplasms (Head and Neck Cancer)
12/2017
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
09/2008
1Chordoma
05/2002
1Chondrosarcoma
05/2002

Drug/Important Bio-Agent (IBA)

9Protons (Proton)IBA
12/2020 - 10/2013
3Biological ProductsIBA
12/2020 - 05/2002
2CarbonIBA
09/2009 - 05/2002
1Dimethyl Sulfoxide (DMSO)FDA LinkGeneric
08/2019
1DNA (Deoxyribonucleic Acid)IBA
08/2019
1Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric
08/2019
1LigandsIBA
08/2019
1Propidium (Propidium Iodide)IBA
08/2019
1trypsin carboxypeptidase peptide inhibitorIBA
12/2017
1IonsIBA
05/2002

Therapy/Procedure

6Radiotherapy
01/2019 - 05/2002
2Proton Therapy
01/2019 - 11/2017
2Lasers (Laser)
11/2017 - 01/2012
1Therapeutics
01/2012
1Heavy Ion Radiotherapy
05/2002